Pfizer Stock – Not the Right Gift This Year
This article is from the archive of The New York Sun before the launch of its new website in 2022. The Sun has neither altered nor updated such articles but will seek to correct any errors, mis-categorizations or other problems introduced during transfer.
Forget about Pfizer ($21.14), for now at least; it’s damaged goods and the wrong holiday present. That’s basically the word from Morningstar, the Chicago-based research house and mutual fund tracker.
A login link has been sent to
Enter your email to read this article.
Get 2 free articles when you subscribe.
or
Have an account? This is also a sign-in form.
By continuing you agree to our Privacy Policy and Terms of Service.
